Retraction Note: RGD peptide-pegylated PLLA nanoparticles containing epirubicin hydrochloride exhibit receptor-dependent tumor trafficking in vitro and in vivo

  • Ping Huang
  • , Jun Wu
  • , Ximeng Li
  • , Xiaozheng Liu
  • , Yinghuan Li
  • , Guohui Cui

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish
Pages (from-to)1050
Number of pages1
JournalPharmaceutical Research
Volume33
Issue number4
DOIs
StatePublished - Apr 1 2016
Externally publishedYes

ASJC Scopus Subject Areas

  • Biotechnology
  • Molecular Medicine
  • Pharmacology
  • Pharmaceutical Science
  • Organic Chemistry
  • Pharmacology (medical)

Cite this